Cargando…

Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants

High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use...

Descripción completa

Detalles Bibliográficos
Autores principales: Pikora, Cheryl A., Sullivan, John L., Panicali, Dennis, Luzuriaga, Katherine
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/
https://www.ncbi.nlm.nih.gov/pubmed/9104802
_version_ 1782148026861617152
author Pikora, Cheryl A.
Sullivan, John L.
Panicali, Dennis
Luzuriaga, Katherine
author_facet Pikora, Cheryl A.
Sullivan, John L.
Panicali, Dennis
Luzuriaga, Katherine
author_sort Pikora, Cheryl A.
collection PubMed
description High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1–specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection.
format Text
id pubmed-2196268
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21962682008-04-16 Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants Pikora, Cheryl A. Sullivan, John L. Panicali, Dennis Luzuriaga, Katherine J Exp Med Article High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1–specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of age. These results provide evidence that young infants can generate HIV-1–specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect against vertical infection. The Rockefeller University Press 1997-04-07 /pmc/articles/PMC2196268/ /pubmed/9104802 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Pikora, Cheryl A.
Sullivan, John L.
Panicali, Dennis
Luzuriaga, Katherine
Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title_full Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title_fullStr Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title_full_unstemmed Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title_short Early HIV-1 Envelope-specific Cytotoxic T Lymphocyte Responses in Vertically Infected Infants
title_sort early hiv-1 envelope-specific cytotoxic t lymphocyte responses in vertically infected infants
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196268/
https://www.ncbi.nlm.nih.gov/pubmed/9104802
work_keys_str_mv AT pikoracheryla earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants
AT sullivanjohnl earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants
AT panicalidennis earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants
AT luzuriagakatherine earlyhiv1envelopespecificcytotoxictlymphocyteresponsesinverticallyinfectedinfants